TBI with hyperlipidaemia | TBI without hyperlipidaemia | IRR* (95% CI) | Adjusted† HR (95% CI) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N | ADs | PY | Rate | N | ADs | PY# | Rate | |||
Age <35 | ||||||||||
Total | 82 | 7 | 651.46 | 107.45 | 164 | 8 | 1335.06 | 59.92 | 1.79 (0.65 to 4.94) | 2.63 (0.58 to 4.71) |
Male | 72 | 7 | 591.77 | 118.29 | 144 | 8 | 1217.52 | 65.71 | 1.80 (0.65 to 4.96) | 1.00 (ref.) |
Female | 10 | 0 | 59.69 | 0.00 | 20 | 0 | 117.53 | 0.00 | N/A<always NA> | N/A |
Age: 35–50 | ||||||||||
Total | 274 | 29 | 1779.58 | 162.96 | 548 | 36 | 3657.26 | 98.43 | 1.66 (1.02 to 2.70)$ | 1.42 (0.82 to 2.47) |
Male | 208 | 16 | 1359.21 | 117.72 | 417 | 18 | 2751.44 | 65.42 | 1.80 (0.92 to 3.53) | 1.00 (ref.) |
Female | 66 | 13 | 420.36 | 309.26 | 131 | 18 | 905.82 | 198.72 | 1.56 (0.76 to 3.18) | 2.81 (1.73 to 4.58)‡ |
Age: 50–65 | ||||||||||
Total | 399 | 53 | 2128.21 | 249.04 | 797 | 53 | 4471.10 | 118.54 | 2.10 (1.44 to 3.07)‡ | 2.54 (1.68 to 3.83)‡ |
Male | 249 | 20 | 1344.10 | 148.80 | 495 | 23 | 2752.23 | 83.57 | 1.78 (0.98 to 3.24) | 1.00 (ref.) |
Female | 150 | 33 | 7847.11 | 420.86 | 302 | 30 | 1718.87 | 174.53 | 2.41 (1.47 to 3.95)‡ | 2.44 (1.65 to 3.60)‡ |
Age: >65 | ||||||||||
Total | 519 | 48 | 2658.16 | 180.58 | 1039 | 80 | 5426.74 | 147.42 | 1.22 (0.86 to 1.75) | 1.13 (0.77 to 1.67) |
Male | 331 | 27 | 1630.31 | 165.61 | 664 | 44 | 3276.11 | 134.31 | 1.23 (0.76 to 1.99) | 1.00 (ref.) |
Female | 188 | 21 | 1027.85 | 204.31 | 375 | 36 | 2150.63 | 167.39 | 1.22 (0.71 to 2.09) | 1.30 (0.92 to 1.85) |
*Estimated with Poisson regression.
†The model was adjusted by gender, hypertension, diabetes mellitus and cardiovascular disease.
‡p<0.001; $p<0.05.
ADs, anxiety disorders; IR, incidence rate, per 10 000 person-years; IRR, incidence rate ratio; N/A, not available; PY, person-year; ref., reference group; TBI, traumatic brain injury.